The activity, pharmacokinetics, pharmacodynamics, efficacy, safety, drug interactions, and dosage and administration of moxifloxacin are reviewed. Moxifloxacin is an oral 8-methoxyquinolone ...

The clinical success rate at 21–28 days post-therapy visit was 84% for moxifloxacin and 74% for the comparators. Uncomplicated Skin and Skin Structure Infections A randomized, double-blind ...

Objective: To compare the real-life treatment of acute exacerbations of chronic bronchitis (AECBs) using moxifloxacin tablets or one of the oral macrolides azithromycin, clarithromycin or ...